Recruiting

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss (SURMOUNT-4)

I8F-MC-GPHN - ClinicalTrials.gov - NCT04660643

The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue tirzepatide or switch to placebo.
How long will I be in the trial?
The study will last about 94 weeks and may include up to 25 visits.
Email
Recruiting

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss (SURMOUNT-4)

I8F-MC-GPHN - ClinicalTrials.gov - NCT04660643

The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue tirzepatide or switch to placebo.
How long will I be in the trial?
The study will last about 94 weeks and may include up to 25 visits.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have obesity or be overweight

Participants must be overweight and have high blood pressure, high cholesterol, sleep apnea or heart disease

Participants must agree to commit to and undergo study procedures as explained by clinic study staff

Participants must NOT

Participants must not have Diabetes

Participants must not have undergone weight loss surgery (e.g. stomach stapling, lap banding)

Participants must not have lost or gained weight in the last 3 months

Participants must not have chronic kidney disease

Participants must not have made prior suicide attempts

Trial Summary

Conditions the trial is for

Overweight, Very Overweight

What the trial is testing?

Tirzepatide

Could I receive a Placebo?

yes

Enrollment Goal

750

Trial Dates

March 2021 - August 2023

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have obesity or be overweight

Participants must be overweight and have high blood pressure, high cholesterol, sleep apnea or heart disease

Participants must agree to commit to and undergo study procedures as explained by clinic study staff

Participants must NOT

Participants must not have Diabetes

Participants must not have undergone weight loss surgery (e.g. stomach stapling, lap banding)

Participants must not have lost or gained weight in the last 3 months

Participants must not have chronic kidney disease

Participants must not have made prior suicide attempts

Trial Summary

Conditions the trial is for

Overweight, Very Overweight

What the trial is testing?

Tirzepatide

Could I receive a Placebo?

yes

Enrollment Goal

750

Trial Dates

March 2021 - August 2023

Trial Phase

3

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?